newcastle.ac.uk Seventy-six per cent of patients with SCH allocated to levothyroxine received a dose of 50 μg daily or less, with 12% taking 75 or 100 μg daily, and a further 12% discontinuing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback